Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(0.0%)
USD 46.75
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 289.86 Million EUR | 342.93% |
| 2022 | 290.61 Million USD | 10.9% |
| 2021 | 262.05 Million USD | 6.5% |
| 2020 | 246.04 Million USD | 10.67% |
| 2019 | 222.33 Million USD | -75.02% |
| 2018 | 889.98 Million EUR | 4.11% |
| 2017 | 854.81 Million EUR | 4.68% |
| 2016 | 816.61 Million EUR | 3.38% |
| 2015 | 789.87 Million EUR | 7.1% |
| 2014 | 737.54 Million EUR | 4.09% |
| 2013 | 708.54 Million EUR | 5.07% |
| 2012 | 674.34 Million EUR | 4.46% |
| 2011 | 645.57 Million EUR | 6.15% |
| 2010 | 608.16 Million EUR | 4.79% |
| 2009 | 580.34 Million EUR | 17.87% |
| 2008 | 492.34 Million EUR | 7.25% |
| 2007 | 459.04 Million EUR | 63.58% |
| 2006 | 280.62 Million EUR | 642.61% |
| 2005 | -51.71 Million EUR | 86.74% |
| 2004 | -389.99 Million EUR | 14.83% |
| 2003 | -457.87 Million EUR | -91.8% |
| 2002 | -238.72 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 360.78 Million EUR | 23.34% |
| 2024 Q2 | 365.12 Million EUR | 1.2% |
| 2023 FY | 1.28 Billion EUR | 342.93% |
| 2023 Q3 | 77.5 Million EUR | 4.33% |
| 2023 Q4 | 292.52 Million EUR | 277.41% |
| 2023 Q1 | 63.46 Million USD | -13.25% |
| 2023 Q2 | 74.29 Million USD | 17.06% |
| 2022 Q4 | 73.16 Million USD | 1.52% |
| 2022 FY | 290.61 Million USD | 10.9% |
| 2022 Q1 | 288.41 Million EUR | 143.15% |
| 2022 Q2 | 303.1 Million EUR | 5.1% |
| 2022 Q3 | 72.06 Million USD | -76.23% |
| 2021 Q2 | 270.49 Million EUR | 0.49% |
| 2021 Q1 | 269.17 Million EUR | -28.27% |
| 2021 Q3 | 277.09 Million EUR | 2.44% |
| 2021 Q4 | 118.61 Million EUR | -57.19% |
| 2021 FY | 262.05 Million USD | 6.5% |
| 2020 Q4 | 375.26 Million EUR | 46.24% |
| 2020 FY | 246.04 Million USD | 10.67% |
| 2020 Q3 | 256.6 Million EUR | 59.41% |
| 2020 Q2 | 160.97 Million EUR | -37.18% |
| 2020 Q1 | 256.24 Million EUR | -65.51% |
| 2019 Q4 | 743.06 Million EUR | 262.37% |
| 2019 FY | 222.33 Million USD | -75.02% |
| 2019 Q2 | 208.25 Million EUR | 0.14% |
| 2019 Q1 | 207.95 Million EUR | -8.21% |
| 2019 Q3 | 205.05 Million EUR | -1.54% |
| 2018 Q2 | 217.59 Million EUR | -1.11% |
| 2018 Q4 | 226.55 Million EUR | 5.46% |
| 2018 FY | 889.98 Million EUR | 4.11% |
| 2018 Q1 | 220.02 Million EUR | 5.75% |
| 2018 Q3 | 214.82 Million EUR | -1.27% |
| 2017 Q3 | 209.8 Million EUR | -4.3% |
| 2017 FY | 854.81 Million EUR | 4.68% |
| 2017 Q1 | 217.72 Million EUR | 6.12% |
| 2017 Q2 | 219.22 Million EUR | 0.69% |
| 2017 Q4 | 208.06 Million EUR | -0.83% |
| 2016 FY | 816.61 Million EUR | 3.38% |
| 2016 Q3 | 200.19 Million EUR | -3.14% |
| 2016 Q2 | 206.69 Million EUR | 1.05% |
| 2016 Q4 | 205.17 Million EUR | 2.49% |
| 2016 Q1 | 204.54 Million EUR | 4.77% |
| 2015 Q3 | 192.8 Million EUR | -5.62% |
| 2015 FY | 789.87 Million EUR | 7.1% |
| 2015 Q4 | 195.22 Million EUR | 1.26% |
| 2015 Q1 | 197.55 Million EUR | 9.79% |
| 2015 Q2 | 204.29 Million EUR | 3.41% |
| 2014 Q4 | 179.93 Million EUR | 1.94% |
| 2014 Q3 | 176.5 Million EUR | -7.46% |
| 2014 Q1 | 190.39 Million EUR | 7.47% |
| 2014 Q2 | 190.72 Million EUR | 0.17% |
| 2014 FY | 737.54 Million EUR | 4.09% |
| 2013 FY | 708.54 Million EUR | 5.07% |
| 2013 Q3 | 171.52 Million EUR | -5.97% |
| 2013 Q2 | 182.42 Million EUR | 2.81% |
| 2013 Q1 | 177.43 Million EUR | 4.47% |
| 2013 Q4 | 177.16 Million EUR | 3.28% |
| 2012 Q3 | 164.79 Million EUR | -2.79% |
| 2012 Q1 | 170.19 Million EUR | 1.99% |
| 2012 Q4 | 169.83 Million EUR | 3.06% |
| 2012 Q2 | 169.52 Million EUR | -0.39% |
| 2012 FY | 674.34 Million EUR | 4.46% |
| 2011 FY | 645.57 Million EUR | 6.15% |
| 2011 Q4 | 166.86 Million EUR | 5.85% |
| 2011 Q3 | 157.64 Million EUR | -1.91% |
| 2011 Q2 | 160.71 Million EUR | -1.31% |
| 2011 Q1 | 162.85 Million EUR | -17.8% |
| 2010 Q2 | 151.7 Million EUR | -1.17% |
| 2010 Q4 | 198.1 Million EUR | 33.44% |
| 2010 Q3 | 148.46 Million EUR | -2.14% |
| 2010 FY | 608.16 Million EUR | 4.79% |
| 2010 Q1 | 153.5 Million EUR | 16.4% |
| 2009 Q2 | 132.05 Million EUR | -0.33% |
| 2009 Q3 | 128.58 Million EUR | -2.62% |
| 2009 Q4 | 131.88 Million EUR | 2.56% |
| 2009 FY | 580.34 Million EUR | 17.87% |
| 2009 Q1 | 132.48 Million EUR | 0.0% |
| 2008 FY | 492.34 Million EUR | 7.25% |
| 2007 FY | 459.04 Million EUR | 63.58% |
| 2006 FY | 280.62 Million EUR | 642.61% |
| 2005 FY | -51.71 Million EUR | 86.74% |
| 2004 FY | -389.99 Million EUR | 14.83% |
| 2003 FY | -457.87 Million EUR | -91.8% |
| 2002 FY | -238.72 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -10023.363% |
| Ansell Limited | 495.5 Million USD | 41.501% |
| Ansell Limited | 495.5 Million USD | 41.501% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -250.063% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -16647.884% |
| Psykey, Inc. | 1.21 Million USD | -23787.085% |
| ConvaTec Group Plc | 910.31 Million USD | 68.158% |
| ConvaTec Group Plc | 872.5 Million USD | 66.778% |
| Encision Inc. | 3.77 Million USD | -7574.995% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -204302.338% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -263579.035% |
| Innovative MedTech Inc. | 6.09 Million USD | -4652.664% |
| LifePoint, Inc. | 7.42 Million USD | -3804.5% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -4465.522% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -33802.339% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -39818.941% |
| Reflect Scientific, Inc. | 1.06 Million USD | -27150.66% |
| SmileDirectClub, Inc. | 517 Million USD | 43.934% |
| Sector 10, Inc. | 39.84 Thousand USD | -727399.749% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 95.637% |
| SheerVision, Inc. | 2.33 Million USD | -12331.834% |
| United Health Products, Inc. | 2.42 Million USD | -11845.615% |
| Vasamed, Inc. | 4.67 Million USD | -6103.089% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -11214.878% |
| Yubo International Biotech Limited | 1.25 Million USD | -22944.023% |